History

Established EditForce, Inc.

Entered into a Joint Research Agreement with Kyushu University on PPR technology

Entered into a Patent License Agreement with Kyushu University to obtain exclusive rights to use PPR technology for RNA.

Opened Fukuoka Laboratory in the campus of Kyushu University

Entered into a Patent License Agreement with Hiroshima University to obtain exclusive rights to use PPR technology related to DNA

Undertook New Energy and Industrial Technology Development Organization (NEDO)'s program of "Development of bio-production technologies of valuable substances using plants / Development of basic and fundamental technologies for bio-production using plant, and Establishment of Japanese technological platform of genome editing"

Opened Tokyo Office in Chuo-ku, Tokyo

Nominated as a "Company Driving Regional Growth" in Fukuoka Prefecture by Ministry of Economy, Trade and Industry

Entered into a Joint Research Agreement with Japan Innovative Therapeutics, Inc.

Relocated Tokyo Office to Minato-ku, Tokyo

Received the JST President's Award at the Awards for Academic Startups 2019, sponsored by Japan Science and Tecknology Agency (JST) and NEDO.

Entered into a Joint Research and Development Agreement with Solasia Pharma K.K.

Adoption of our genetic therapy development program in "Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-Generation Treatment and Diagnosis (Development of RNA-targeted drug discovery technology)" by Japan Agency for Medical Research and Development (AMED)

Entered into a License Agreement with Mitsubishi Tanabe Pharma Corporation to grant rights to research, develop and commercialize drugs for a specific CNS disease.

Relocated Tokyo Office to Chiyoda-ku, Tokyo

Adoption of our program "EF-210" in "Strengthening Program for Pharmaceutical Startup Ecosystem" by AMED